QA: Cellectar Biosciences Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001279704_2020_Cellectar_Biosciences_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001279704, Cellectar Biosciences Inc

  xvar xval
0 AssetsCurrent 11,385,673
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 435,083
3 remainder_Assets 430,055
4 LiabilitiesCurrent 2,769,758
5 LiabilitiesNoncurrent 421,644
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,060,906
9 ResearchAndDevelopmentExpense 8,222,610
10 remainder_Expenses 1,148,836
11 remainder_Revenues 0
12 remainder_NetIncome 85,476
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 12,250,811
1 Liabilities 3,191,402
2 Expenses 14,432,352
3 Revenues 0
4 StockholdersEquity 9,059,409
5 NetIncome -14,346,876
6 ComprehensiveNetIncome -14,346,876
7 BaseVar 14,980,020
8 EconomicCapitalRatiobeforeLimitedLiability 0.700
9 EconomicCapitalRatio 2.06

Edgar->Model Mapping

Feature Distribution

Change over Time